NCT01662375View on ClinicalTrials.gov

A Prospective Study Evaluating the Feasibility and Ethical Perspective of Maastricht III Organ Procurement in French Intensive Care Unit Patients

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

July 31, 2014

Conditions
Intensive CareSupportive CareWithdrawal of Life Support
Interventions
OTHER

Surveillance and interview

The interventional nature of the study is justified by the need for particular monitoring of patients in whom life support is withdrawn following the clinical team's decision. The questions posed to the patient's family and/or relatives, do not modify the care provided to the patient.

Trial Locations (1)

44093

CHU de Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01662375 - A Prospective Study Evaluating the Feasibility and Ethical Perspective of Maastricht III Organ Procurement in French Intensive Care Unit Patients | Biotech Hunter | Biotech Hunter